Biotechnology Industry Organization (BIO) Elects New Chair, Officers, and Board Members
4/23/2013 6:43:28 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The Biotechnology Industry Organization (BIO) is pleased to announce the election of Rachel King, President and CEO, GlycoMimetics, Inc, as the new Chair of its Board of Directors for the 2013-2014 term, and the election of David Pyott, Chairman, President, & CEO, Allergan, Inc., as its new Board Secretary. BIO also is pleased to announce the re-election of Mark Skaletsky, Chairman & CEO, Fenway Pharmaceuticals, Inc., as Board Treasurer, and the election of 19 Directors to serve on BIO’s Board Executive Committee for the new term. In addition, BIO welcomes the election of eight new members to its Board of Directors, voted upon at this year’s 2013 BIO International Convention.
Help employers find you! Check out all the jobs and post your resume.